Atlas Trials

Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects

Clinical trial NCT02074995 · TERMINATED

Trial details

NCT number
NCT02074995
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypercatabolic Status Related to Severe Burn
Start date
2014-02-01
Primary completion
2015-01-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.